Sustained Growth Hormone Axis Activation Stack
Mechanistic Synergy for Research:
- CJC-1295 DAC is a long-acting GHRH analog that promotes sustained pituitary GH release through GHRH receptor activation and extended half-life.
- Ipamorelin is a highly selective GHRP (Growth Hormone Releasing Peptide) that stimulates GH release via the ghrelin receptor (GHS-R1a) without significant cortisol or prolactin elevation.
Combined Benefits:
- Dual GH Pulse Stimulation: CJC-1295 (GHRH) and Ipamorelin (GHRP) act synergistically at the hypothalamic-pituitary axis, increasing GH secretion amplitude and duration.
- Anabolic Support: GH promotes IGF-1 expression, muscle protein synthesis, and fat metabolism in research models.
- Recovery & Regeneration: Enhanced GH levels improve soft tissue healing, metabolic adaptation, and nitrogen retention.
Use Cases:
GH axis stimulation studies, anabolic recovery research, muscle growth and repair models.
